Skip to main content

Epidemiology of Lung Cancer

  • Chapter
  • First Online:

Part of the book series: Contemporary Medical Imaging ((CMI))

Abstract

Lung cancer is the leading cause of cancer death in the United States, claiming an estimated 157,300 victims in 2010. In 1950, three separate studies were published that suggested cigarette smoking was associated with increased risk of lung cancer. This and subsequent research revealed a clear dose–response relationship between amount of cigarettes smoked and lung cancer incidence, offering further proof of its association with the dramatic increase in lung cancer rates seen during the 1900s. Since then, an ever-expanding body of evidence continues to identify cigarette smoking as the single most important cause of lung cancer. The prevention, diagnosis, and treatment of lung cancer will continue to be of major importance in the coming decades. Primary prevention strategies that prevent exposure to risk factors such as cigarette smoke, asbestos, and radon hold promise for continuing to achieve reductions in the population burden of lung cancer. Preventive efforts contributing to this trend extend from the arena of public policy down to individual behavior modification. By far the most central strategy needs to be continued emphasis on prevention of initiation and cessation of smoking.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. American Cancer Society. Cancer facts and figures 2010. Atlanta: American Cancer Society; 2010.

    Google Scholar 

  2. Doll R, Hill AB. Smoking and carcinoma of the lung; preliminary report. Br Med J. 1950;2(4682): 739–48.

    Article  PubMed  CAS  Google Scholar 

  3. Levin ML, Goldstein H, Gerhardt PR. Cancer and tobacco smoking; a preliminary report. J Am Med Assoc. 1950;143(4):336–8.

    Article  PubMed  CAS  Google Scholar 

  4. Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. J Am Med Assoc. 1950;143(4):329–36.

    Article  PubMed  CAS  Google Scholar 

  5. Doll R, Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health. 1978;32(4):303–13.

    Article  PubMed  CAS  Google Scholar 

  6. Doll R, Hill AB. Lung cancer and other causes of death in relation to smoking; a second report on the mortality of British doctors. Br Med J. 1956;2: 1071–81.

    Article  PubMed  CAS  Google Scholar 

  7. U.S. Public Health Service. Smoking and health. Report of the Advisory Committee to the surgeon general. US Department of Health, Education, and Welfare, Public Health Service, Center for Diseases Control. PHS publication no. 1103. Washington, DC: GPO; 1964.

    Google Scholar 

  8. White C. Research on smoking and lung cancer: a landmark in the history of chronic disease epidemiology. Yale J Biol Med. 1990;63(1):29–46.

    PubMed  CAS  Google Scholar 

  9. US National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: incidence—SEER 9 Regs Limited-Use, Nov 2007 Sub (1973–2008), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011, based on the November 2010 submission.

    Google Scholar 

  10. US National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov) SEER*Stat Database: incidence—SEER 17 Regs Limited-Use + Hurricane Katrina impacted Louisiana cases, Nov 2010 Sub (1973–2007 varying), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011, based on the November 2010 submission.

  11. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 2003;123(1 Suppl):21S–49S.

    Article  PubMed  Google Scholar 

  12. US National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov) SEER*Stat Database: mortality—all COD, aggregated with state, total U.S. (1969–2007), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011. Underlying mortality data provided by NCHS http://www.cdc.gov/nchs

  13. Haiman CA, Stram DO, Wilkens LR, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006;354(4):333–42.

    Article  PubMed  CAS  Google Scholar 

  14. Pinsky PF. Racial and ethnic differences in lung cancer incidence: how much is explained by differences in smoking patterns? (United States). Cancer Causes Control. 2006;17(8):1017–24.

    Article  PubMed  Google Scholar 

  15. Belani CP, Marts S, Schiller J, Socinski M. Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer. 2007;55(1):15–23.

    Article  PubMed  Google Scholar 

  16. Thun MJ, Jemal A. How much of the decrease in cancer death rates in the United States is attributable to reductions in tobacco smoking? Tob Control. 2006;15(5):345–7.

    Article  PubMed  Google Scholar 

  17. International Early Lung Cancer Action Program Investigators, Henschke CI, Yip R, Miettinen OS. Women’s susceptibility to tobacco carcinogenesis and survival after diagnosis of lung cancer. JAMA. 2006;296(2):180–4.

    Article  PubMed  Google Scholar 

  18. Mao Y, Hu J, Ugnat AM, Semenciw R, Fincham S. Canadian cancer registries epidemiology research group. Socioeconomic status and lung cancer risk in Canada. Int J Epidemiol. 2001;30(4):809–17.

    Article  PubMed  CAS  Google Scholar 

  19. Li K, Yu S. Economic status, smoking, occupational exposure to rubber, and lung cancer: a case-cohort study. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2002;20(1):21–8.

    Article  PubMed  CAS  Google Scholar 

  20. van Loon AJ, Goldbohm RA, Kant IJ, Swaen GM, Kremer AM, van den Brandt PA. Socioeconomic status and lung cancer incidence in men in The Netherlands: is there a role for occupational exposure? J Epidemiol Community Health. 1997;51(1):24–9.

    Article  PubMed  Google Scholar 

  21. Ekberg-Aronsson M, Nilsson PM, Nilsson JA, Pehrsson K, Löfdahl CG. Socio-economic status and lung cancer risk including histologic subtyping—a longitudinal study. Lung Cancer. 2006;51(1):21–9.

    Article  PubMed  Google Scholar 

  22. Toh C-K, Gao F, Lim WT, et al. Differences between small-cell lung cancer and non-small-cell lung cancer among smokers. Lung Cancer. 2007;56(2):161–6.

    Article  PubMed  Google Scholar 

  23. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC, editors. World Health Organization Classification of Tumours: Pathology and Genetics of tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press; 2004.

    Google Scholar 

  24. Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol. 2006;24(28):4539–44.

    Article  PubMed  Google Scholar 

  25. Sun Z, Yang P. Gene expression profiling on lung cancer outcome prediction: present clinical value and future premise. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2063–8.

    Article  PubMed  CAS  Google Scholar 

  26. Beane J, Sebastiani P, Whitfield TH, et al. A prediction model for lung cancer diagnosis that integrates genomic and clinical features. Cancer Prev Res (Phila). 2008;1(1):56–64.

    Article  Google Scholar 

  27. Director’s Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma, Shedden K, Taylor JM, et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med. 2008;14(8):822–7.

    Article  PubMed  CAS  Google Scholar 

  28. Samet JM. Lung cancer. In: Greenwald P, Kramer BS, Weed DL, editors. Cancer prevention and control. New York, NY: Marcel Dekker, Inc.; 1995. p. 561–4.

    Google Scholar 

  29. Peto R. Influence of dose and duration of smoking on lung cancer rates. IARC Sci Publ. 1986;74: 23–33.

    PubMed  Google Scholar 

  30. US Department of Health and Human Services (US-DHHS). Smoking and health: a national status report. Washington, DC: US Government Printing Office; 1987.

    Google Scholar 

  31. Alberg AJ, Ford JG, Samet JM, American College of Chest Physicians. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 Suppl):29S–55S.

    Article  PubMed  CAS  Google Scholar 

  32. Wu X, Lin J, Etzel CJ, et al. Interplay between mutagen sensitivity and epidemiological factors in modulating lung cancer risk. Int J Cancer. 2007;120(12): 2687–95.

    Article  PubMed  CAS  Google Scholar 

  33. Smoking and Tobacco Control Monograph 9. Cigars: health effects and trends. NIH publication no. 98–4302. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health (NIH), National Cancer Institute; 1998.

    Google Scholar 

  34. Boffetta P, Pershagen G, Jöckel KH, et al. Cigar and pipe smoking and lung cancer risk: a multicenter study from Europe. J Natl Cancer Inst. 1999;91(8): 697–701.

    Article  PubMed  CAS  Google Scholar 

  35. Mehra R, Moore BA, Crothers K, Tetrault J, Fiellin DA. The association between marijuana smoking and lung cancer. Arch Intern Med. 2006;166(13): 1359–67.

    Article  PubMed  CAS  Google Scholar 

  36. Hashibe M, Straif K, Tashkin DP, Morgenstern H, Greenland S, Zhang ZF. Epidemiologic review of marijuana use and cancer risk. Alcohol. 2005;35(3): 265–75.

    Article  PubMed  CAS  Google Scholar 

  37. American Cancer Society. Cancer prevention & early detection facts & figures 2007. Atlanta: American Cancer Society; 2007.

    Google Scholar 

  38. US Department of Health and Human Services. The health benefits of smoking cessation. A report of the surgeon general [DHHS publication number 90–8416]. Washington, DC: U.S. Government Printing Office, US Department of Health and Human Services; 1990.

    Google Scholar 

  39. Hrubec Z, McLaughlin JK. Former cigarette smoking and mortality among U.S. veterans: a 26-year follow-up, 1954–1980. In: Burns D, Garfinkel L, Samet JM, editors. Changes in cigarette-related disease risks and their implication for prevention and control. Bethesda, MD: U.S. Government Printing Office; 1997. p. 501–30.

    Google Scholar 

  40. Fiore M, Bailey W, Cohen S. Treating tobacco use and dependence. Clinical practice guideline. Rockville, MD: US Department of Health and Human Services. Public Health Service; 2000.

    Google Scholar 

  41. Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med. 2008;35(2):158–76.

    Article  Google Scholar 

  42. Centers for Disease Control and Prevention (US). Best practices for comprehensive tobacco control programs—August 1999. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1999.

    Google Scholar 

  43. US Department of Health and Human Services. The health consequences of involuntary smoking: a report of the surgeon general. DHHS publication no. (CDC) 87–8398. Washington, DC: U.S. Government Printing Office; 1986.

    Google Scholar 

  44. US Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the surgeon general. Washington, DC: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease and Prevention and Health Promotion, Office of Smoking and Health; 2006.

    Google Scholar 

  45. Boffetta P. Involuntary smoking and lung cancer. Scand J Work Environ Health. 2002;28 Suppl 2:30–40.

    PubMed  CAS  Google Scholar 

  46. Taylor R, Cumming R, Woodward A, Black M. Passive smoking and lung cancer: a cumulative meta-analysis. Aust N Z J Public Health. 2001;25(3):203–11.

    Article  PubMed  CAS  Google Scholar 

  47. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981;66(6):1191–308.

    PubMed  CAS  Google Scholar 

  48. Alberg AJ, Yung R, Strickland PT, Nelson J. Respiratory cancer and exposure to arsenic, chromium, nickel and polycyclic aromatic hydrocarbons. Clin Occup Environ Med. 2002;2:779–801.

    Article  Google Scholar 

  49. Lynch KM, Smith WA. Pulmonary asbestosis: V. A report of bronchial carcinoma and epithelial metaplasia. Am J Cancer. 1939;36(4):567–73.

    Google Scholar 

  50. Wedler HW. Asbestosis and pulmonary carcinoma (asbestose und lungenkrebs). Bull Hyg. 1944;19:362.

    Google Scholar 

  51. Doll R. Mortality from lung cancer in asbestos workers. Br J Ind Med. 1955;12(2):81–6.

    PubMed  CAS  Google Scholar 

  52. Selikoff IJ, Churg J, Hammond EC. Asbestos exposure and neoplasia. JAMA. 1964;188(1):22–6.

    Article  PubMed  CAS  Google Scholar 

  53. Selikoff IJ, Hammond EC, Seidman H. Mortality experience of insulation workers in the United States and Canada, 1943–1976. Ann N Y Acad Sci. 1979;330:91–116.

    Article  PubMed  CAS  Google Scholar 

  54. Newhouse ML, Berry G. Patterns of mortality in asbestos factory workers in London. Ann N Y Acad Sci. 1979;330:53–60.

    Article  PubMed  CAS  Google Scholar 

  55. Wraith D, Mengersen K. Assessing the combined effect of asbestos exposure and smoking on lung cancer: a Bayesian approach. Stat Med. 2007;26(5): 1150–69.

    Article  PubMed  CAS  Google Scholar 

  56. Churg A, Stevens B. Enhanced retention of asbestos fibers in the airways of human smokers. Am J Respir Crit Care Med. 1995;151(5):1409–13.

    Article  PubMed  CAS  Google Scholar 

  57. MacMahon B. Some recent issues in low-exposure radiation epidemiology. Environ Health Perspect. 1989;81:131–5.

    Article  PubMed  CAS  Google Scholar 

  58. Boice Jr JD. Studies of atomic bomb survivors. Understanding radiation effects. JAMA. 1990; 264(5):622–3.

    Article  PubMed  Google Scholar 

  59. Pierce DA, Sharp GB, Mabuchi K. Joint effects of radiation and smoking on lung cancer risk among atomic bomb survivors. Radiat Res. 2003;159(4):511–20.

    Article  PubMed  CAS  Google Scholar 

  60. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950–1997. Radiat Res. 2003; 160(4):381–407.

    Article  PubMed  CAS  Google Scholar 

  61. Hendee WR. Estimation of radiation risks. BEIR V and its significance for medicine. JAMA. 1992;268(5):620–4.

    Article  PubMed  CAS  Google Scholar 

  62. Prise KM, Folkard M, Michael BD. Bystander responses induced by low LET radiation. Oncogene. 2003;22(45):7043–9.

    Article  PubMed  CAS  Google Scholar 

  63. Hall EJ, Hei TK. Genomic instability and bystander effects induced by high-LET radiation. Oncogene. 2003;22(45):7034–42.

    Article  PubMed  CAS  Google Scholar 

  64. Institute of Medicine. Health effects of exposure to radon (BEIR VI). Washington, DC: National Academy Press, National Research Council (NRC), Committee on Health Risks of Exposure to Radon, Board on Radiation Effects Research, Commission on Life Sciences; 1999.

    Google Scholar 

  65. Pirozynski M. 100 years of lung cancer. Respir Med. 2006;100(12):2073–84.

    Article  PubMed  Google Scholar 

  66. Lubin JH, Boice Jr JD, Edling C, et al. Lung cancer in radon-exposed miners and estimation of risk from indoor exposure. J Natl Cancer Inst. 1995;87(11): 817–27.

    Article  PubMed  CAS  Google Scholar 

  67. National Research Council of the National Academies, Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation. Health risks from exposure to low levels of ionizing radiation BEIR VII-phase 2. Washington, DC: The National Academies Press; 2005.

    Google Scholar 

  68. Schmid K, Kuwert T, Drexler H. Radon in indoor spaces: an underestimated risk factor for lung cancer in environmental medicine. Dtsch Arztebl Int. 2010;107(11):181–6.

    PubMed  Google Scholar 

  69. Shimizu Y, Kato H, Schull WJ. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950–1985: part 2. Cancer mortality based on the recently revised doses (DS86). Radiat Res. 1990;121(2):120–41.

    Article  PubMed  CAS  Google Scholar 

  70. Davis FG, Boice Jr JD, Hrubec Z, Monson RR. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res. 1989;49(21):6130–6.

    PubMed  CAS  Google Scholar 

  71. Howe GR. Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the atomic bomb survivors study. Radiat Res. 1995;142(3):295–304.

    Article  PubMed  CAS  Google Scholar 

  72. Prochazka M, Hall P, Gagliardi G, et al. Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: case-only design. J Clin Oncol. 2005;23(30): 7467–74.

    Article  PubMed  Google Scholar 

  73. Kaufman EL, Jacobson JS, Hershman DL, Desai M, Neugut AI. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol. 2008;26(3):392–8.

    Article  PubMed  Google Scholar 

  74. Lorigan P, Radford J, Howell A, Thatcher N. Lung cancer after treatment for Hodgkin’s lymphoma: a systematic review. Lancet Oncol. 2005;6(10):773–9.

    Article  PubMed  Google Scholar 

  75. Rajaraman P, Sigurdson AJ, Doody MM, et al. Lung cancer risk among US radiologic technologists, 1983–1998. Int J Cancer. 2006;119(10):2481–6.

    Article  PubMed  CAS  Google Scholar 

  76. Boffetta P, Mannetje A, Zaridze D, et al. Occupational X-ray examinations and lung cancer risk. Int J Cancer. 2005;115(2):263–7.

    Article  PubMed  CAS  Google Scholar 

  77. de González AB, Kim KP, Samet JM. Radiation-induced cancer risk from annual computed tomography for patients with cystic fibrosis. Am J Respir Crit Care Med. 2007;176(10):970–3.

    Article  PubMed  Google Scholar 

  78. National Research Council. Epidemiology and air pollution. Washington, DC: National Academy Press, National Research Council (NRC), Commission on Life Sciences, Board on Toxicology and Environmental Health Hazards, Committee on the Epidemiology of Air Pollutants; 1985. p. 1–224.

    Google Scholar 

  79. Laden F, Hart JE, Eschenroeder A, Smith TJ, Garshick E. Historical estimation of diesel exhaust exposure in a cohort study of U.S. railroad workers and lung cancer. Cancer Causes Control. 2006;17(7): 911–9.

    Article  PubMed  Google Scholar 

  80. Davis ME, Smith TJ, Laden F, et al. Driver exposure to combustion particles in the U.S. trucking industry. J Occup Environ Hyg. 2007;4(11):848–54.

    Article  PubMed  CAS  Google Scholar 

  81. Garshick E, Laden F, Hart JE, et al. Lung cancer and vehicle exhaust in trucking industry workers. Environ Health Perspect. 2008;116:1327–32.

    Article  PubMed  Google Scholar 

  82. Dockery DW, Pope III CA, Xu X, et al. An association between air pollution and mortality in six U.S. cities. N Engl J Med. 1993;329(24):1753–9.

    Article  PubMed  CAS  Google Scholar 

  83. Pope III CA, Thun MJ, Namboodiri MM, et al. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med. 1995;151(3 Pt 1):669–74.

    Article  PubMed  Google Scholar 

  84. Raaschou-Nielsen O, Bak H, Sørensen M, et al. Air pollution from traffic and risk for lung cancer in three Danish cohorts. Cancer Epidemiol Biomarkers Prev. 2010;19(5):1284–91.

    Article  PubMed  CAS  Google Scholar 

  85. Health Effects Institute. Asbestos in public and commercial buildings: a literature review and a synthesis of current knowledge. Cambridge, MA: Health Effects Institute, Asbestos Research Committee, Literature Review Panel; 1991.

    Google Scholar 

  86. Lan Q, Chapman RS, Schreinemachers DM, Tian L, He X. Household stove improvement and risk of lung cancer in Xuanwei, China. J Natl Cancer Inst. 2002;94(11):826–35.

    Article  PubMed  Google Scholar 

  87. Kleinerman RA, Wang Z, Wang L, et al. Lung cancer and indoor exposure to coal and biomass in rural China. J Occup Environ Med. 2002;44(4):338–44.

    Article  PubMed  Google Scholar 

  88. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR; 2007.

    Google Scholar 

  89. Lam TK, Gallicchio L, Lindsley K, et al. Cruciferous vegetable consumption and lung cancer risk: a systematic review. Cancer Epidemiol Biomarkers Prev. 2009;18(1):184–95.

    Article  PubMed  CAS  Google Scholar 

  90. Celik I, Gallicchio L, Boyd K, et al. Arsenic in drinking water and lung cancer: a systematic review. Environ Res. 2008;108(1):48–55.

    Article  PubMed  CAS  Google Scholar 

  91. Tardon A, Lee WJ, Delgado-Rodriguez M, et al. Leisure-time physical activity and lung cancer: a meta-analysis. Cancer Causes Control. 2005;16(4): 389–97.

    Article  PubMed  Google Scholar 

  92. Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 2007;176(3):285–90.

    Article  PubMed  Google Scholar 

  93. Littman AJ, Thornquist MD, White E, Jackson LA, Goodman GE, Vaughan TL. Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control. 2004;15(8):819–27.

    Article  PubMed  Google Scholar 

  94. Cicenas S, Vencevicius V. Lung cancer in patients with tuberculosis. World J Surg Oncol. 2007;5:22.

    Article  PubMed  Google Scholar 

  95. Aoki K. Excess incidence of lung cancer among pulmonary tuberculosis patients. Jpn J Clin Oncol. 1993;23(4):205–20.

    PubMed  CAS  Google Scholar 

  96. Ramanakumar AV, Parent ME, Menzies D, Siemiatycki J. Risk of lung cancer following nonmalignant respiratory conditions: evidence from two case–control studies in Montreal, Canada. Lung Cancer. 2006;53(1):5–12.

    Article  PubMed  Google Scholar 

  97. Wu AH, Fontham ET, Reynolds P, et al. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol. 1995;141(11):1023–32.

    PubMed  CAS  Google Scholar 

  98. Brenner AV, Wang Z, Kleinerman RA, et al. Previous pulmonary diseases and risk of lung cancer in Gansu province, China. Int J Epidemiol. 2001;30(1): 118–24.

    Article  PubMed  CAS  Google Scholar 

  99. Matakidou A, Eisen T, Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer. 2005;93(7): 825–33.

    Article  PubMed  CAS  Google Scholar 

  100. Schwartz AG, Yang P, Swanson GM. Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol. 1996;144(6):554–62.

    Article  PubMed  CAS  Google Scholar 

  101. Shields PG. Molecular epidemiology of smoking and lung cancer. Oncogene. 2002;21(45):6870–6.

    Article  PubMed  CAS  Google Scholar 

  102. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst. 2000;92(11):874–97.

    Article  PubMed  CAS  Google Scholar 

  103. Robles AI, Linke SP, Harris CC. The p53 network in lung carcinogenesis. Oncogene. 2002;21(45): 6898–907.

    Article  PubMed  CAS  Google Scholar 

  104. Vineis P, Manuguerra M, Kavvoura FK, et al. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst. 2009;101(1):24–36.

    Article  PubMed  CAS  Google Scholar 

  105. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334(18):1150–5.

    Article  PubMed  CAS  Google Scholar 

  106. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330(15):1029–35.

    Google Scholar 

  107. Gallicchio L, Boyd K, Matanoski G, et al. Carotenoids and the risk of developing lung cancer: a systematic review. Am J Clin Nutr. 2008;88(2): 372–83.

    PubMed  CAS  Google Scholar 

  108. Jackson MI, Combs Jr GF. Selenium and anticarcinogenesis: underlying mechanisms. Curr Opin Clin Nutr Metab Care. 2008;11(6):718–26.

    Article  PubMed  CAS  Google Scholar 

  109. Clark LC, Combs GF, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA. 1996; 276(24):1957–63.

    Article  PubMed  CAS  Google Scholar 

  110. Mahabir S, Spitz MR, Barrera SL, Beaver SH, Etzel C, Forman MR. Dietary zinc, copper and selenium, and risk of lung cancer. Int J Cancer. 2007;120(5): 1108–15.

    Article  PubMed  CAS  Google Scholar 

  111. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA. 2009; 301(1):39–51.

    Article  PubMed  CAS  Google Scholar 

  112. Bosetti C, Gallus S, La Vecchia C. Aspirin and cancer risk: an updated quantitative review to 2005. Cancer Causes Control. 2006;17(7):871–88.

    Article  PubMed  Google Scholar 

  113. Hernández-Díaz S, García Rodríguez LA. Nonsteroidal anti-inflammatory drugs and risk of lung cancer. Int J Cancer. 2007;120(7):1565–72.

    Article  PubMed  CAS  Google Scholar 

  114. Harris RE, Beebe-Donk J, Alshafie GA. Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies. Subcell Biochem. 2007;42:193–212.

    Article  PubMed  Google Scholar 

  115. Setoguchi S, Glynn RJ, Avorn J, Mogun H, Schneeweiss S. Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation. 2007;115(1):27–33.

    Article  PubMed  CAS  Google Scholar 

  116. Khurana V, Bejjanki HR, Caldito G, Owens MW. Statins reduce the risk of lung cancer in humans: a large case–control study of US veterans. Chest. 2007;13(5):1282–8.

    Article  Google Scholar 

  117. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970–2002. JAMA. 2005;294(10):1255–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anthony J. Alberg Ph.D., M.P.H. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Wheless, L., Brashears, J., Alberg, A.J. (2013). Epidemiology of Lung Cancer. In: Ravenel, J. (eds) Lung Cancer Imaging. Contemporary Medical Imaging. Humana Press, New York, NY. https://doi.org/10.1007/978-1-60761-620-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-620-7_1

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-60761-619-1

  • Online ISBN: 978-1-60761-620-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics